期刊文献+

PAA包覆MCM-41 pH敏感释药系统的制备和释药研究 被引量:1

Synthesis and pH-Sensitive Drug Release Performance of PAA Coating MCM-41
在线阅读 下载PDF
导出
摘要 采用微波法合成了介孔分子筛MCM-41,将其与氢氯噻嗪组装,组装后分子筛与丙烯酸(AA)原位聚合,形成了一种具有pH敏感性的释药系统。通过FT-IR、XRD对材料进行表征,研究了其在人工胃液和人工肠液中的释药行为,结果表明,材料在人工肠液中的释药速率明显大于在胃液中的释药速率,可用于肠道靶向给药。 Mesoporous molecular sieve MCM-41 is synthesized by the microwave method. Diuretic hudrochlorothiazide is introduced into MCM-41, and is polymerized with polyacrylic acid(PAA) via in situ. Thus a typical com- posite material which is sensitive to pH is prepared. The material is characterized by FT-IR, XRD, simulatedgastrie fluid and simulated intestinal fluid are used to study the different drug release. Results show that hydrochlorothiazide release is much faster in simulated intestinal fluid. Therefore, this material can be used in the area of intestinal targeting drug release.
出处 《材料导报》 EI CAS CSCD 北大核心 2010年第16期46-48,56,共4页 Materials Reports
基金 中国博士后科学基金(20080440696) 重庆大学"211工程"三期创新人才培养研究生开放实验室项目(S-09103) 重庆大学研究生创新基金(201005A1A0010332) 国家大学生创新基金(081061119081061119)
关键词 MCM-41 PAA pH敏感释药 MCM-41, polyacrylie acid, pH sensitive drug release
  • 相关文献

参考文献12

  • 1Barbe C, Bartlett J, Kong L G, et al. Silica particles a novel drug-delivery system[J], Adv Mater,2004,16(2) :1959.
  • 2Qu F Y, Zhu G S, Huang S Y, et al. Effective controlled release of captopril by silylation of mesoporous MCM-41[J]. Chem Phys Chem, 2006,7 (2) : 400.
  • 3Doadrio J C, Sousa E M B, Izquierdo-Barba I, et al. Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern[J]. J Mater Chem, 2006,16 (5) : 462.
  • 4Andersson J, Rosenholm J, Areva S, et al. Influences of material characteristics on ibuprofen drug loading and release profiles from ordered microand mesoporous silica matrices[J]. Chem Mater,2004,16(21) ..4160.
  • 5曹渊,白英豪,徐艳.氢氯噻嗪/MCM-41载药体系的制备与缓释作用研究[J].材料导报,2007,21(F11):226-228. 被引量:7
  • 6Vallet-Regi M, Ramila A, Real R P del, et al. A new property of MCM-41: Drug delivery system[J]. Chem Mater, 2001,13(2):308.
  • 7Munoz B, Ramila A, Perez-Pariente J, et al. MCM-41 organic modification as drug delivery rate regulator[J]. Chem Mater, 2003,15 (2) : 500.
  • 8曹渊,白英豪,夏之宁.不同孔径介孔分子筛MCM–41的合成及载药释药性能(英文)[J].硅酸盐学报,2009,37(9):1570-1574. 被引量:11
  • 9Zeng W, Qian X F, Zhang Y B, et al. Organic modified mesoporous MCM-41 through solvothermal process as drug de livery system[J]. Mater Res Bull, 2005,40 (5) : 766.
  • 10Song S W, Hidajat K, Kawi S. Functionalized SBA 15 materials as carriers for controlled drug delivery: Influence of surface properties on matrix-drug interactions [J]. Langmuir, 2005,21 (21) : 9568.

二级参考文献13

  • 1张君,吴秀文,马鸿文,李金鸿.不同孔径MCM-41介孔分子筛的合成及吸附性能研究[J].材料导报,2006,20(F05):216-218. 被引量:9
  • 2Kresge C T, Leonowicz M E, Roth W J,et al. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism[J]. Nature, 1992,359 : 710.
  • 3Beck J S,Vartuli J C,Roth W J, et al. A new family of mesoporous molecular sieves prepared with liquid crystal templates[J]. J Am Chem Soc, 1992,114(27) : 10834.
  • 4Chamary C, Begu S, Tourne-Peteilh C, et al. Inclusion of ibuprofen in mesoporous templated silica, drug loading and release property[J]. Eur J Pharmaceutics, 2004,57(3) : 533.
  • 5Horcajada P, Ramila A, Perez-Pariente J, et al. Influence of pore size of MCM-41 matrices on drug delivery rate[J]. Microp Mesop Mater, 2004,68 : 15.
  • 6Vallet-Regi M, Doadrio J C, Deadrio A I, et al. Hexagonal ordered mesoporous material as a matrix for the controlled release of amoxicillin[J]. Solid State Ionics, 2004, 172 ( 1- 4):43.
  • 7Rdmila A, Mmoz B, Perez-Pariente J, et al. Mesoporous MCM-41 as drug host system [J]. J Sol-gel Sci Techn, 2003,26:1199.
  • 8Heikkila T, Salonen J,Tuura J, et al. Mesoporous silica material TUD-1 as a drug delivery system[J]. Int J Pharmaceutics, 2007,331 : 133.
  • 9Gennara Cavallaro, Paola Pierro, Fabio Palurnbo, et al. Drug delivery devices based on mesoporous silicate [J]. Drug Delivery, 2004, 11(1):41.
  • 10Munoz B, Rdmila A, Perez-Pariente J, et al. MCM-41 organic modification as drug delivery rate regulator[J]. Chem Mater, 2003,15 (2):500.

共引文献15

同被引文献19

  • 1曲凤玉,朱广山,黄世英,李守贵,裘式纶.水溶性药物巯甲丙脯酸/Si-MCM-41载药新体系的制备与缓释作用研究[J].高等学校化学学报,2004,25(12):2195-2198. 被引量:16
  • 2曲凤玉,崔凌飞,黄世英,朱广山.介孔分子筛孔道结构对药物巯甲丙脯酸释放性能的影响[J].高等学校化学学报,2007,28(8):1440-1442. 被引量:11
  • 3Yan AX, Li XW, Ye YH. Recent progress on immobilization of enzymes on molecular sieves for reactions in organic sol- vents. Appl Biochem Biotech ,2002,101 : 113-129.
  • 4QuYF(曲凤玉).A controlled release of drug molecules byassembly and self-assembly drug in mesoporous silica. Changchun: Jilin University, PhD. 2006.
  • 5Lng TP, Dan AL, Charnay C, et al. The potential of ordered mesoporous silica for the storage of drugs:the example of a pentapeptide encapsulated in a MSU-tween 80. Chemphy- schem ,2003 , 4 : 281-286.
  • 6XuRR(徐如人),PangWQ(庞文琴).Chemistry-Zeolitesand Porous Materials(分子筛与多孔材料化学).Beijing:Science Press ,2004. 126-130.
  • 7Araki H, Fukuoka A, Sakamoto Y, et al. Template synthesis and characterization of gold nano-wires and particles in me- sopomus channels of FSM-16. J Mol Catal A-Chem,2003, 199:95-102.
  • 8Arbiol J, Cabot A, Morante JR, et al. Distributions of noble metal Pd and Pt in mesoporous silica. Appl Phys Lett,2002, 81 : 3449 -3451.
  • 9Crowley TA, Ziegler K.I, Lyons DM, et al. Synthesis of metal and metal oxide nanowire and nanotube arrays within a meso- porous silica template. Chem Mater,2003,15:3518-3522.
  • 10Fukuoka A, Shakamoto Y, Guan S, et al. Novel templating synthesis of necklace-shaped mono and bimetallic nanowires in hybrid organic-inorganic mesoporous material. J Am Chem Soc ,2001,123 : 3373-3374.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部